Prognostic factors of recurrent HCC after surgery include vascular invasion, tumor size, and expression of cancer stem/progenitor cells (CSPC) markers such as CD90 (i.e., recurrence-related CSPC marker) and CD133 (4). The gene discussed is GZMH; the disease is neoplasm.